3SBio Inc., of Shenyang, China, named Jing Lou board chairman and added Dongmei Su to its board...Anaphore Inc., of La Jolla, Calif., added Peppi Prasit and Raymond Stevens to its board...Silence Therapeutics plc, of London, appointed Detlef Schuppan and Massimo Pinzani to its newly created scientific advisory board

Sirona also appointed Sean Cunliffe chief business officer and board member...Trovagene Inc., of San Diego, named Charlie Rodi vice president and chief technology officer...ValiRx plc, of London, named Hilary Calvert, Richard Harbottle and Jean-Frederic Sauniere to its scientific advisory board

The revisions will reflect technological advancements and marketing developments that have emerged over the past decade...Viewed as a way to take the hard choices of curbing Medicare expenses out of the hands of Congress, the board – made up of presidential appointments confirmed by the Senate – is charged with cutting Medicare costs if its spending exceeds a predetermined target growth rate. (See BioWorld Today, July 14, 2011, and Sept. 20, 2011.) Although President Barack Obama has proposed

It also added John E. Dick and Janet Rossant to its scientific and clinical advisory board...Zealand Pharma A/S, of Copenhagen, Denmark, named Alain Munoz and Christian Grøndahl joint chairs to its new clinical and scientific advisory board

Pharmalink AB, of Stockholm, Sweden, elected Anders Wiklung chairman and added Elisabeth Lindner to the board...Promosome LLC, of New York, added Edward R. Robinson and Loren A. Busby to its board...It also appointed Louis Brenner chief medical officer and elected Kurt Graves chairman

NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

NeoStem Inc., of New York, appointed Martyn D. Greenacre and Andrew L. Pecora to the board...NexImmune Inc., of Gaithersburg, Md., appointed Kenneth Carter CEO and named Jonathan Schneck chairman of the clinical and scientific advisory board

InteRNA Technologies BV, of Utrecht, the Netherlands, appointed Mark Vaeck and Sanne Weijzen to its board chaired by Anker Lundemose...It also named Robert B. Shapiro and Jeffrey B. Kindler to its board

Emerald BioStructures Inc., of Bainbridge Island, Wash., appointed Johan Pontin chairman and CEO...Fate Therapeutics Inc., of San Diego, appointed William H. Rastetter chairman and interim CEO...Forma Therapeutics Inc., of Watertown, Mass., named Jaime Escobedo vice president of biology and Mark J. Tebbe vice president of medicinal and computational chemistry and appointed Dennis France executive director and head of biomolecular screening

Codexis Inc., of Redwood City, Calif., named Wesley J. Bolsen vice president and chief marketing officer...Curis Inc., of Lexington, Mass., appointed Maurizio Voi chief medical and chief development officer

Accera Inc., of Broomfield, Colo., appointed Holger Kunze CEO and board member...BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards...CBio Ltd., of Brisbane, Australia, named Ralph Craven chairman and appointed Helen Cameron interim managing director

Hilary Malone as vice president and chief regulatory and compliance officer...and Jim Rouse as vice president and chief information officer

Lycera Corp., of Ann Arbor, Mich., named Kathleen M. Metters president and CEO...Medivir AB, of Huddinge, Sweden, appointed Maris Hartmanis president and CEO...PDL BioPharma Inc., of Incline Village, Nev., retained Franklin M. Berger and Evan Bedil as advisors to assist with the identification and evaluation of royalty-bearing asset acquisition opportunities

Dyax Corp., of Cambridge, Mass., appointed Ron Cohen and Paolo Pucci to its board...Scott L. Friedman and Maria Isabel Fiel were named as consultants...Horizon Pharma Inc., of Northbrook, Ill., appointed Michael Grey and Ronald Pauli to its board

It also named Gerald Commissiong president and CEO and appointed Owen Garrick strategic advisor to its board...Anaptys Bio Inc., of San Diego, named Carol G. Gallagher executive chair and promoted Hamza Suria to chief business officer and acting CEO

and Alan W. Dunton as consulting chief medical officer...Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer...and Jens D. Kristensen as executive vice president of clinical

Creabilis SA, of Luxembourg, named Alex Leech vice president and head of finance of operations, appointed James Sandy senior vice president and head of development and added Peter Spargo as senior vice president for chemistry, manufacturing and controls

Tim Henkel as executive vice president and head of R&D...Doug Gessl as chief operating officer and chief financial officer...and Lisa Wittmer as vice president of regulatory affairs

PharmacoFore Inc., of San Carlos, Calif., appointed Joseph Stauffer chief medical officer and vice president of corporate strategy and named Narinder Banait vice president of intellectual property...ProtAffin AG, of Graz, Austria, appointed Frank Walsh chairman and named Tim Edwards to the board